Skip to main content
. 2022 Dec 8;10:rbac099. doi: 10.1093/rb/rbac099

Figure 7.

Figure 7.

(A and B) The viability of the A549 cells after incubation in the supernatants from DOX-co-loaded MPs. (A): P00—control, PD0—DOX-loaded, P0G—p53-loaded, PDG DOX-co-p53-loaded PLGA MPs [90], (B): MP-1—control, MP-2—miR-519c-loaded, MP-3—DOX-loaded, MP-4—DOX-co-miR-519c-loaded PLGA MPs [107], and the lung weights after in vivo test of BALB/c mice 4 weeks after H226 cancer cells implementation and DOX/TRAIL-loaded PLGA MPs pulmonary administration (*P < 0.015 over group I; **P < 0.005 over group II; and ***P < 0.05 over group IV) [91]. All the pictures adapted with permission.